A human endometrial cancer cell line, HEC-1, was found to be resistant to the antiviral and anticeUular action of interferon. However, HEC-1 cells were susceptible to the cytotoxicity of natural killer (NK) cells, and interferon enhanced such NK activity. When HEC-1 cells were treated with interferon, sensitivity of HEC cells to the cytotoxicity of NK cells was not suppressed.
Interferons exhibit not only antiviral action, but various anticellular activities (Gresser, 1977a; Gresser et al., 1979) . Interferons suppress the growth of cells by acting directly on them (Gresser, 1977 b; Gresser & Tovey, 1978) and at the same time indirectly by activating the cytotoxicity of natural killer cells (Trinchieri & Santoli, 1978; Herberman et al., 1979) or macrophages (Schultz & Chirigos, 1978) . Whether either the direct or indirect effect of interferon or both plays a crucial role in the suppression of tumour growth is still not clear. On the other hand, the sensitivities of cells to interferons vary (Adams et al., 1975; Hilfenhaus et al., 1977) . The antiviral action of interferon and the cell growth-inhibiting action of interferons are expressed in parallel in various cells (Gresser et al., 1970; Gresser et aL, 1974) . However, in certain cases, cells are sensitive to the antiviral action, but resistant to the cell growth-inhibiting action of interferon (Kuwata et al., 1976; Kuwata et al., 1979; Fuchsberger et aL, 1974) . Recently, we have found a human adenocarcinoma cell line, HEC-I, which is resistant to the antiviral and anticellular action of interferon. In this report we describe the biological characteristics of HEC-1 cells including its sensitivity to cytotoxicity of natural killer cells.
HEC-1 cells were originally isolated from a human endometrial cancer and established in vitro by Kuramoto et al. (1972) . This cell line was supplied by S. Sekiya, Department of Obstetrics and Gynecology of our Medical School. The original karyotype of HEC-1 cells was near diploid but at the present time it is hypertriploid. The human transformed cell line RSb was used for comparison, since RSb cells are characterized by their high sensitivity to the cell growth-inhibiting action of interferon (Kuwata et aL, 1976) . These cells were cultivated using Eagle's minimal essential medium (MEM) supplemented with 10% calf serum. Human leukocyte interferon (HulFN-a) was kindly supplied by Dr Karl Cantell of the Central Public Health Laboratory, Helsinki, Finland. The specific activity was 4 × 106 reference units/mg protein. Fibroblast interferon (HulFN-fl) was a gift from Dr A. BiUiau and was the same preparation as used previously (Sato et al., 1979) .
HEC-1 and RSb cells were compared in their sensitivity to the antiviral action of HulFN-a. As shown in Table 1 , HEC-1 cells were sensitive to vesicular stomatitis virus (VSV) infection even after treatment with 1000 units/ml HulFN-a or HulFN-fl. To clarify this phenomenon, the binding of interferon to these cells was investigated. About 107 cells were treated with 1000 units/ml HulFN-a for 2 h. Then, cells were washed three times with MEM, scraped from culture dishes and sonicated as described previously (Kuwata et al., 1976) . About 1% of the total amount of interferon applied was recovered from the interferon-sensitive RSb cells, whereas only 0.1% or less was recovered from HEC-1 cells. Thus, it is conceivable that there * Cells grown in 6 cm diam. plastic dishes were treated with interferon for about 20 h, washed once with MEM and then challenged with about 1 TCIDso/cell of vesicular stomatitis virus (VSV). After 3 to 15 h, culture fluids were harvested and stored at --75 °C. The yield of virus was titrated as described using RSa cells.
+ Hours after VSV challenge.
were fewer receptors for interferon in HEC-1 cells. The interferon receptor on the plasma membrane of human cells has been reported to be coded for by chromosome 21 (Tan, 1977; Slate et al., 1978) . We could detect three or four copies of chromosome 21 in our HEC-1 cells. Therefore, reduction of recoverable interferon was not due to a decrease in chromosome 21.
On the other hand, recent studies have revealed that expression of the antiviral action of interferon may depend on the induction of two double-stranded RNA-activated enzymes: 2'-5'-oligoadenylate synthetase and a protein kinase (Farrell et al., 1978; Baglioni, 1979) . In HEC-1 cells, however, these enzymes are both present in untreated cells and are not enhanced by interferon treatment (Verhaegen et al., 1980) . HEC-1 cells were also resistant to the cell growth-inhibiting action of HuIFN-¢t. (Fig. 1 a) . Continuous treatment of HEC-1 cells with 5000 units/ml HuIFN-¢t suppressed the growth of cells only slightly. Since HEC-t cells have been already passaged many times, it is not clear whether this cell line was interferon resistant from the beginning of its in vitro culture or has become interferon resistant during later passages. The latter possibility cannot be excluded. We have demonstated the isolation of interferon-resistant variant cells from interferonsensitive RSa cells in the presence of interferon. On the other hand, RSb cells were sensitive to HuIFN-a and 500 units/ml HuIFN-tt suppressed the growth by about 90% of the control in 6 days of treatment.
Recently it has been demonstrated that interferon enhances the cytotoxicity of natural killer (NK) cells in vitro (Trinchieri & Santoli, 1978; Herberman et al., 1979) and in vivo (Gidlund et al., 1978) . This action of interferon is considered to be one of the factors which suppress growth of tumour cells. Therefore, we examined the sensitivity of HEC-1 cells to NK action in comparison with RSb cells. Although HEC-1 cells were less sensitive to NK cell action than RSb cells, interferon treatment enhanced the NK activity against HEC-1 cells (Fig. 1 b) . The same results were obtained when interferon was added to the mixture of lymphocytes and HEC-1 cells. also reported that interferon induced cytotoxicity against cells refractory to lysis by unstimulated effectors. When RSb cells were treated with various concentrations of HuIFN-fl, the sensitivity of these cells to the cytotoxicity of NK cells decreased in proportion to the amount of interferon applied (Fig. 1 c) as reported in other cell systems (Trinchieri & Santoli, 1978; . However, when HEC-1 cells were treated with interferon and then mixed with NK cells, the sensitivity of HEC-1 to NK cell activity was not suppressed at all (Fig. 1 e, d) . It is not yet clear what factors determine the sensitivity of cells to the cytotoxicity of NK cells. Cell surface configuration and function may be considered one such factor, and evidence has accumulated that interferon modifies the cell surface (Friedman, 1978a, b) , while interferon treatment enhances binding of Con A to [] El, HEC-1 cells mixed with another set of lymphocytes. Effector lymphocytes were pretreated with various doses of HulFN-fl for 2 h. Preparation of effeetor lymphocytes and cytotoxicity assays were performed as described (Sam et aL, 1979) , except that the 51Cr-labelled target cell suspension was mixed with lymphocytes and the assay time was 6 h. Amounts of 0.1 ml of a target cell suspension were mixed with equal volumes of a lymphocyte suspension to yield a lymphocyte to target cell ratio of 80 in U-shaped microtitre plates. The plates were incubated at 37 °C in 5% CO2 in air for 6 h and then after centrifuging at 1000 rev/min for 4 min, 0.1 ml supernatant was collected for counting in a gamma spectrometer. The spontaneous release did not exceed 15%. plasma membranes in several cell strains (Huet et al., 1974; Kuwata et al., 1980) . However, HEC-I cells were rather resistant to such action of interferon . Although HEC-I cells are insensitive to the direct action of human interferon, they are still sensitive to interferon-stimulated NK action. This fact may imply that interferons are effective even against tumours resistant to the growth-inhibiting action of interferons. It has been already reported that interferon-resistant mouse L1210 R cells are sensitive to interferon action in vivo (Gresser et al., 1972) . These, and our experiments, suggest that interferon treatment may exert a favourable influence on the suppression of interferon-resistant tumours in human cases. In this connection it has been reported that NK cell activities are enhanced in patients following interferon therapy (Einhorn et al., 1978; Huddlestone et al., 1979) . This work was supported by a grant from the Ministry of Education, Science and Culture. We are grateful to Dr Sofuni, National Institute of Hygienic Sciences, Tokyo, for his kind help in chromosome analysis. 
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